https://www.eurekalert.org/news-releases/1000838
News
Is This Drug the Next COPD Breakthrough?
https://www.healthcentral.com/condition/copd/dupixent-drug-breakthrough-for-copd-fda-decision
Dupixent® (Dupilumab) Demonstrates Potential to Become First Biologic to Treat COPD
https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-demonstrates-potential-become-first-biologic
Therapeutic Solutions International Advances Chronic Obstructive Pulmonary Disease Program
https://www.businesswire.com/news/home/20230313005444/en/Therapeutic-Solutions-International-Advances-Chronic-Obstructive-Pulmonary-Disease-Program-by-Identifying-Novel-B-Regulatory-Cell-Mechanism-of-Action-for-JadiCell-Universal-Donor-Adult-Stem-Cell
Synairgen announces positive data from interim analysis of SNG001 trial in COPD patients
https://www.globenewswire.com/news-release/2020/09/08/2089903/0/en/Synairgen-announces-positive-data-from-interim-analysis-of-SNG001-trial-in-COPD-patients.html Synairgen announces positive data from interim analysis of SNG001 trial in COPD patients
Drug development for severe respiratory diseases supported with $3.9 million grant: New drug candidate targets asthma, COPD, other progressive lung diseases
Drug development for severe respiratory diseases supported with $3.9 million grant Drug development for severe respiratory diseases supported with $3.9 million grant New drug candidate targets asthma, COPD, other progressive lung diseases
AstraZeneca Wins FDA Approval for COPD Treatment
https://www.biospace.com/article/fda-approves-astrazeneca-s-copd-treatment-breztri-aerosphere/ AstraZeneca Wins FDA Approval for COPD Treatment
Verona Pharma Raises $200 Million to support Phase 3 ENHANCE clinical program in COPD
https://www.globenewswire.com/news-release/2020/07/17/2063777/0/en/Verona-Pharma-Raises-200-Million-in-Oversubscribed-Private-Placement-and-Subscription.html Verona Pharma Raises $200 Million to support Phase 3 ENHANCE clinical program in COPD
Twice-daily Budesonide/Glycopyrrolate/Formoterol Significantly Lowered Exacerbations in Patients with Moderate or Severe COPD
https://www.mdmag.com/conference-coverage/ats-2020/budesonide-lama-laba-reduces-annual-copd-exacerbation Budesonide Plus LAMA/LABA Significantly Reduces Annual COPD Exacerbation Twice-daily budesonide/glycopyrrolate/formoterol significantly lowered exacerbations in patients with moderate or severe chronic obstructive pulmonary disease (COPD) versus a pair of double therapy inhalers, according to new findings.
Lung Denervation System Named FDA Breakthrough Device
Lung Denervation System Named FDA Breakthrough Device Lung Denervation System Named FDA Breakthrough Device
Nuvaira Announces FDA Breakthrough Designation for AIRFLOW-3 Pivotal Trial Device
https://www.nuvaira.com/nuvaira-announces-fda-breakthrough-designation-for-airflow-3-pivotal-trial-device/ Nuvaira Announces FDA Breakthrough Designation for AIRFLOW-3 Pivotal Trial Device
A New Report Confirms Significant Benefits in Patient Reported Outcomes at One Year Following the Non-Surgical Zephyr Valve Procedure for COPD/Emphysema
https://www.businesswire.com/news/home/20200512005517/en/New-Report-Confirms-Significant-Benefits-Patient-Reported A New Report Confirms Significant Benefits in Patient Reported Outcomes at One Year Following the Non-Surgical Zephyr Valve Procedure for COPD/Emphysema
Lung Volume Reduction Coil Treatment Enables Recovery in Severe COPD Cases
https://www.ajmc.com/newsroom/lung-volume-reduction-coil-treatment-enables-recovery-in-severe-copd-cases Lung Volume Reduction Coil Treatment Enables Recovery in Severe COPD Cases
Inhalation therapy shows promise against pulmonary fibrosis in mice, rats
https://medicalxpress.com/news/2020-02-inhalation-therapy-pulmonary-fibrosis-mice.html Inhalation therapy shows promise against pulmonary fibrosis in mice, rats
Verona Pharma announces publication of Phase 2b clinical trial results for ensifentrine, a maintenance treatment for chronic obstructive pulmonary disease (COPD)
https://www.biospace.com/article/releases/verona-pharma-announces-publication-of-key-phase-2b-copd-data-in-respiratory-researchpaper-demonstrates-ensifentrine-s-potential-in-improving-lung-function-and-quality-of-life-symptoms Verona Pharma Announces Publication of Key Phase 2b COPD Data – Paper demonstrates ensifentrine’s potential in improving lung function and quality of life symptoms
New hope for COPD patients possible with in-home device
https://www.sciencedaily.com/releases/2020/02/200204163646.htm New hope for COPD patients possible with in-home device Date: February 4, 2020 Source: Mayo Clinic Summary: Researchers describe the benefits of in-home noninvasive ventilation therapy, which includes a type referred to as bilevel positive airway pressure, or BiPAP — for many patients with chronic obstructive pulmonary disease (COPD). The team identified a number […]
Verona Pharma Reports Positive Top-line Data in Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy
https://www.globenewswire.com/news-release/2020/01/13/1969219/0/en/Verona-Pharma-Reports-Positive-Top-line-Data-in-4-Week-Phase-2b-COPD-Study-with-Nebulized-Ensifentrine-on-Top-of-Tiotropium-Therapy.html Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy
Cancer drugs could potentially treat COPD
https://www.sciencedaily.com/releases/2020/01/200106103446.htm https://www.sheffield.ac.uk/news/nr/cancer-drugs-can-treat-copd-1.877500 Cancer drugs could potentially treat COPD Date: January 6, 2020 Source: University of Sheffield Summary: New research has shown the potential for clinically available cancer treatments to treat chronic obstructive pulmonary disease (COPD). Our research now shows that inhibitors of these cell signalling processes, or ErbB kinases, could have therapeutic potential in neutrophilic […]
Antiarrhythmic drug could also treat PAH, COPD
https://www.cardiovascularbusiness.com/topics/hypertension/antiarrhythmic-drug-could-also-treat-pah-copd Antiarrhythmic drug could also treat PAH, COPD
There’s now a life-changing treatment (Zephyr valve system) for COPD patients in Georgia
https://www.wsbtv.com/news/local/theres-new-life-changing-treatment-copd-patients-georgia/BLM4NI6DORHZLKZJJP7NASIV7M/ There’s now a life-changing treatment for COPD patients in Georgia
New Research Gives Hope for Slowing Progression and Mortality of Chronic Obstructive Pulmonary Disease (COPD)
https://www.copdfoundation.org/About-Us/Press-Room/Press-Releases/Article/1515/New-Research-Gives-Hope-for-Slowing-Progression-and-Mortality-of-Fourth-Leading.aspx New Research Gives Hope for Slowing Progression and Mortality of Chronic Obstructive Pulmonary Disease (COPD)
COPD Foundation: COPD Awareness Month is Here!
https://www.copdfoundation.org/About-Us/Press-Room/Press-Releases/Article/1510/COPD-Awareness-Month-is-Here.aspx COPD Awareness Month is Here!
Oscillating Vest Keeps COPD Patients Out of Hospital: Exacerbations reduced with technology initially designed for use in CF
https://www.medpagetoday.com/meetingcoverage/chest/82898 Oscillating Vest Keeps COPD Patients Out of Hospital Exacerbations reduced with technology initially designed for use in CF
Temple AIRFLOW-3 trial offers new approach to treating COPD
https://6abc.com/health/temple-airflow-3-trial-offers-new-approach-to-treating-copd/5638840/
Verona Pharma Completes Enrollment in Phase 2b Clinical Trial for Ensifentrine in moderate-to-severe COPD
https://www.biospace.com/article/releases/verona-pharma-completes-enrollment-in-phase-2b-clinical-trial-with-nebulized-ensifentrine-in-moderate-to-severe-copdresults-to-inform-development-plan-and-dose-selection-for-phase-3/ Verona Pharma Completes Enrollment in Phase 2b Clinical Trial with Nebulized Ensifentrine in moderate-to-severe COPDResults to Inform Development Plan and Dose Selection for Phase 3
Bayer Will Invest $30M in Joint Research Lab for COPD, Other Chronic Lung Diseases
Bayer Will Invest $30M in Joint Research Lab for Chronic Lung Diseases Bayer Will Invest $30M in Joint Research Lab for COPD, Other Chronic Lung Diseases
Verona Pharma to Present Phase 2 Symptom Data with Ensifentrine (RPL554) in COPD at CHEST 2019
http://www.globenewswire.com/news-release/2019/10/15/1929421/0/en/Verona-Pharma-to-Present-Phase-2-Symptom-Data-with-Ensifentrine-in-COPD-at-CHEST-2019.html Verona Pharma to Present Phase 2 Symptom Data with Ensifentrine in COPD at CHEST 2019
AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients
https://www.globenewswire.com/news-release/2019/09/25/1920526/0/en/AzurRx-BioPharma-Announces-Positive-Results-from-Phase-2-Trial-with-MS1819-in-Cystic-Fibrosis-Patients.html AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients
AstraZeneca to present next wave of science in respiratory disease at ERS International Congress
https://www.astrazeneca.com/media-centre/press-releases/2019/astrazeneca-to-present-next-wave-of-science-in-respiratory-disease-at-ers-international-congress-25092019.html AstraZeneca to present next wave of science in respiratory disease at ERS International Congress
PT010 Phase III ETHOS Trial Met Its Primary Endpoint in COPD
https://www.biospace.com/article/pt010-phase-iii-ethos-trial-met-its-primary-endpoint-in-copd/ PT010 Phase III ETHOS Trial Met Its Primary Endpoint in COPD
Circassia Pharma Receives 2nd FDA Approval for COPD Treatment in 2 Weeks
https://www.biospace.com/article/circassia-pharma-receives-2nd-fda-approval-for-copd-treatment-in-2-weeks/
Circassia Announces FDA Approval of Duaklir for Maintenance Treatment of Chronic Obstructive Pulmonary Disease
https://www.circassia.com/media/press-releases/circassia-announces-fda-approval-of-duaklir-for-maintenance-treatment-of-chronic-obstructive-pulmonary-disease/
AI-powered digital treatment can aid COPD treatment: Study
http://www.digitaljournal.com/life/health/ai-powered-digital-treatment-can-aid-copd-treatment-study/article/544910
Queen’s Researchers make breakthrough in chronic lung disease
https://www.qub.ac.uk/News/Allnews/QueensResearchersmakebreakthroughinchroniclungdisease.html
Verona announces positive results from Phase II COPD trial
http://www.pharmatimes.com/news/verona_announces_positive_results_from_phase_ii_copd_trial_1280333
WebMD: Daily Aspirin Might Ease COPD Flare-Ups
https://www.webmd.com/lung/copd/news/20190304/daily-aspirin-might-ease-copd-flare-ups
Nuvaira Raises $79M for COPD Treatment Device
https://www.mddionline.com/nuvaira-raises-79m-copd-treatment-device
New COPD treatment at UofL Hospital is a ‘landmark development’
https://www.whas11.com/article/news/new-copd-treatment-at-uofl-hospital-is-a-landmark-development/417-0c0be1d0-5819-40bb-bb64-e4b433fd0b6f https://www.pulmonx.com/en/ous/professionals/products/zephyr-endobronchial-valve/
Researchers breathe new life into COPD research using mouse models
https://www.sciencedaily.com/releases/2019/01/190131113843.htm Researchers breathe new life into COPD research using mouse models Date: January 31, 2019 Source: Tokyo Medical and Dental University Summary: Researchers revealed that the immune cells basophils caused emphysema in mice with COPD-like features induced by intranasal administration of elastase. They showed that basophils, previously linked mainly to allergies and fighting parasites, initiated […]
FDA Approves Generic Inhalation Treatment for Asthma, COPD
https://www.pharmacytimes.com/resource-centers/asthma/fda-approves-generic-inhalation-treatment-for-asthma-copd FDA Approves Generic Inhalation Treatment for Asthma, COPD
FDA approves first generic Advair Diskus
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm630151.htm FDA approves first generic Advair Diskus
Inhalable MRNA: New Delivery Method Could Help Treat Patients Of Lung Disease
https://www.evolving-science.com/health/inhalable-mrna-00895 Inhalable MRNA: New Delivery Method Could Help Treat Patients Of Lung Disease
New Shock Treatment Showing Promise For COPD Patients
https://pittsburgh.cbslocal.com/2019/01/07/copd-treatment-lung-shock/ New Shock Treatment Showing Promise For COPD Patients
Engineers create an inhalable form of messenger RNA
https://news.mit.edu/2019/inhalable-messenger-rna-lung-disease-0104 Engineers create an inhalable form of messenger RNA
Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment
https://www.medgadget.com/2018/12/tevas-proair-digihaler-fda-approved-to-monitor-asthma-and-copd-treatment.html Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment
Synairgen Developing COPD Treatment To Hold Off Further Viral Damage
https://scrip.pharmaintelligence.informa.com/SC124368/Synairgen-Developing-COPD-Treatment-To-Hold-Off-Further-Viral-Damage Synairgen Developing COPD Treatment To Hold Off Further Viral Damage
Zapping airway nerves may help COPD patients breathe
https://www.health24.com/Medical/COPD/News/zapping-airway-nerves-may-help-copd-patients-breathe-20180918 Zapping airway nerves may help COPD patients breathe
FDA Approves Revefenacin, a Once-a-Day Nebulized LAMA, for COPD
https://www.ajmc.com/newsroom/fda-approves-revefenacin-a-onceaday-nebulized-lama-for-copdFDA Approves Revefenacin, a Once-a-Day Nebulized LAMA, for COPD
Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI™ (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease
https://www.prnewswire.com/news-releases/theravance-biopharma-and-mylan-receive-fda-approval-for-yupelri-revefenacin-in-adults-with-chronic-obstructive-pulmonary-disease-300747672.html
Zapping Airway Nerves May Help COPD Patients
https://www.webmd.com/lung/copd/news/20180918/zapping-airway-nerves-may-help-copd-patients#1Zapping Airway Nerves May Help COPD Patients
Testosterone replacement therapy could slow the progression of COPD
Testosterone replacement therapy could slow the progression of COPD Testosterone replacement therapy could slow the progression of COPD
FDA-Approved Valve Treatment For COPD Seeing Positive Results
https://pittsburgh.cbslocal.com/2018/07/24/copd-fda-approved-valve-treatment/ FDA-Approved Valve Treatment For COPD Seeing Positive Results
FDA approves novel device for treating breathing difficulty from severe emphysema
FDA approves novel device for treating breathing difficulty from severe emphysema https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm612271.htm
